Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10
Mutations in a common extracellular domain of fibroblast growth factor receptor (FGFR)-2 isoforms (type IIIb and IIIc) cause craniosynostosis syndrome and chondrodysplasia syndrome. FGF10, a major ligand for FGFR2-IIIb and FGFR1-IIIb, is a key participant in the epithelial-mesenchymal interactions r...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-06-01
|
| Series: | Bone Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352187223000402 |
| _version_ | 1797798086712492032 |
|---|---|
| author | Hirotaka Yoshioka Kazuko Kagawa Tomoko Minamizaki Masashi Nakano Jane E. Aubin Katsuyuki Kozai Kazuhiro Tsuga Yuji Yoshiko |
| author_facet | Hirotaka Yoshioka Kazuko Kagawa Tomoko Minamizaki Masashi Nakano Jane E. Aubin Katsuyuki Kozai Kazuhiro Tsuga Yuji Yoshiko |
| author_sort | Hirotaka Yoshioka |
| collection | DOAJ |
| description | Mutations in a common extracellular domain of fibroblast growth factor receptor (FGFR)-2 isoforms (type IIIb and IIIc) cause craniosynostosis syndrome and chondrodysplasia syndrome. FGF10, a major ligand for FGFR2-IIIb and FGFR1-IIIb, is a key participant in the epithelial-mesenchymal interactions required for morphogenetic events. FGF10 also regulates preadipocyte differentiation and early chondrogenesis in vitro, suggesting that FGF10-FGFR signaling may be involved in craniofacial skeletogenesis in vivo. To test this hypothesis, we used a tet-on doxycycline-inducible transgenic mouse model (FGF10 Tg) to overexpress Fgf10 from embryonic day 12.5. Fgf10 expression was 73.3-fold higher in FGF10 Tg than in wild-type mice. FGF10 Tg mice exhibited craniofacial anomalies, such as a short rostrum and mandible, an underdeveloped (cleft) palate, and no tympanic ring. Opposite effects on chondrogenesis in different anatomical regions were seen, e.g., hyperplasia in the nasal septum and hypoplasia in the mandibular condyle. We found an alternative splicing variant of Fgfr2-IIIb with a predicted translation product lacking the transmembrane domain, and suggesting a soluble form of FGFR2-IIIb (sFGFR2-IIIb), differentially expressed in some of the craniofacial bones and cartilages. Thus, excessive FGF10 may perturb signal transduction of the FGF-FGFR, leading to craniofacial skeletal abnormalities in FGF10 Tg mice. |
| first_indexed | 2024-03-13T03:58:10Z |
| format | Article |
| id | doaj.art-93dbd4f4b9ff4dc8b1bf65f9cd289dd4 |
| institution | Directory Open Access Journal |
| issn | 2352-1872 |
| language | English |
| last_indexed | 2024-03-13T03:58:10Z |
| publishDate | 2023-06-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Bone Reports |
| spelling | doaj.art-93dbd4f4b9ff4dc8b1bf65f9cd289dd42023-06-22T05:03:19ZengElsevierBone Reports2352-18722023-06-0118101692Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10Hirotaka Yoshioka0Kazuko Kagawa1Tomoko Minamizaki2Masashi Nakano3Jane E. Aubin4Katsuyuki Kozai5Kazuhiro Tsuga6Yuji Yoshiko7Department of Anatomy, School of Medicine, International University of Health and Welfare, Chiba, Japan; Department of Calcified Tissue Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Correspondence to: H. Yoshioka, Department of Anatomy, School of Medicine, International University of Health and Welfare, 4-3 Kozunomori, Narita, Chiba 286-8686, Japan.Department of Calcified Tissue Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Department of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanDepartment of Calcified Tissue Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanDepartment of Calcified Tissue Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Department of Pediatric Dentistry, Division of Oral Health and Development, Hiroshima University Hospital, Hiroshima, JapanDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, CanadaDepartment of Pediatric Dentistry, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanDepartment of Advanced Prosthodontics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanDepartment of Calcified Tissue Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Correspondence to: Y. Yoshiko, Department of Calcified Tissue Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minamiku, Hiroshima 734-8553, Japan.Mutations in a common extracellular domain of fibroblast growth factor receptor (FGFR)-2 isoforms (type IIIb and IIIc) cause craniosynostosis syndrome and chondrodysplasia syndrome. FGF10, a major ligand for FGFR2-IIIb and FGFR1-IIIb, is a key participant in the epithelial-mesenchymal interactions required for morphogenetic events. FGF10 also regulates preadipocyte differentiation and early chondrogenesis in vitro, suggesting that FGF10-FGFR signaling may be involved in craniofacial skeletogenesis in vivo. To test this hypothesis, we used a tet-on doxycycline-inducible transgenic mouse model (FGF10 Tg) to overexpress Fgf10 from embryonic day 12.5. Fgf10 expression was 73.3-fold higher in FGF10 Tg than in wild-type mice. FGF10 Tg mice exhibited craniofacial anomalies, such as a short rostrum and mandible, an underdeveloped (cleft) palate, and no tympanic ring. Opposite effects on chondrogenesis in different anatomical regions were seen, e.g., hyperplasia in the nasal septum and hypoplasia in the mandibular condyle. We found an alternative splicing variant of Fgfr2-IIIb with a predicted translation product lacking the transmembrane domain, and suggesting a soluble form of FGFR2-IIIb (sFGFR2-IIIb), differentially expressed in some of the craniofacial bones and cartilages. Thus, excessive FGF10 may perturb signal transduction of the FGF-FGFR, leading to craniofacial skeletal abnormalities in FGF10 Tg mice.http://www.sciencedirect.com/science/article/pii/S2352187223000402FGF10FGFR2Craniofacial skeletonChondrogenesis |
| spellingShingle | Hirotaka Yoshioka Kazuko Kagawa Tomoko Minamizaki Masashi Nakano Jane E. Aubin Katsuyuki Kozai Kazuhiro Tsuga Yuji Yoshiko Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10 Bone Reports FGF10 FGFR2 Craniofacial skeleton Chondrogenesis |
| title | Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10 |
| title_full | Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10 |
| title_fullStr | Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10 |
| title_full_unstemmed | Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10 |
| title_short | Developmental impairments of craniofacial bone and cartilage in transgenic mice expressing FGF10 |
| title_sort | developmental impairments of craniofacial bone and cartilage in transgenic mice expressing fgf10 |
| topic | FGF10 FGFR2 Craniofacial skeleton Chondrogenesis |
| url | http://www.sciencedirect.com/science/article/pii/S2352187223000402 |
| work_keys_str_mv | AT hirotakayoshioka developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 AT kazukokagawa developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 AT tomokominamizaki developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 AT masashinakano developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 AT janeeaubin developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 AT katsuyukikozai developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 AT kazuhirotsuga developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 AT yujiyoshiko developmentalimpairmentsofcraniofacialboneandcartilageintransgenicmiceexpressingfgf10 |